MSF at the 72nd World Health Assembly

Proposed by Italy in February 2019, the resolution is now being sponsored by ten countries: Italy, Greece, Malaysia, Portugal, Serbia, Slovenia, South Africa, Spain, Turkey, and Uganda. If passed, it would be a major step towards improving affordable prices for all essential medical tools worldwide. Today, a lack of transparency around what different countries pay for medicines, and the actual cost of researching, developing and manufacturing a particular medicine, allows pharmaceutical corporations to charge exorbitant and arbitrary prices.

MSF protests at J&J’s annual shareholders meeting to demand a say in how lifesaving tuberculosis drug developed with considerable joint efforts, including public funding and MSF operational research, will be made available and affordable.

Medical humanitarian organisation uses ‘Humanitarian Mechanism’ programme to access affordable versions of pneumonia vaccine to protect refugee children in Greece against the number one childhood killer worldwide